S. Ercan (Izmir, Turkey), I. Kontsevaya (Borstel, Germany)
Disseminated tuberculosis is associated with more false negative interferon gamma release assay results compared to localized tuberculosis
S. Shah (Luton, United Kingdom), M. Eisenhut (Luton, United Kingdom)
|   |
Mutational profile of gyrA and gyrB genes associated with fluoroquinolones (FQs) resistance among drug resistant tuberculosis patients: an observational study
V. Bajiya (Jodhpur, India), C. Choudhary (Jodhpur, India), G. Purohit (Jodhpur, India), A. Kuwal (Jodhpur, India), A. Mohanty (Jodhpur, India)
| |
Variability of resistance of Mycobacterium tuberculosis based on whole genome sequencing in patients with MDR and XDR-TB in the Kharkiv region,Ukraine
T. Butova (Kharkiv, Ukraine), M. Kuzhko (Kyiv, Ukraine), O. Solodiankin (Kharkiv, Ukraine), N. Rudova (Kharkiv, Ukraine), A. Tkachenko (Kharkiv, Ukraine), D. Butov (Kharkiv, Ukraine), M. Harris (Bethesda, United States), A. Gabrielian (Bethesda, United States), D. Hurt (Bethesda, United States), A. Rosenthal (Bethesda, United States)
| |
The alternation of gut microbiome composition can predict latent tuberculosis infection status in poorly-controlled diabetic patients: A prospective case-controll study
H. Huang (Kaohsiung, Taiwan), J. Wang (Taipei, Taiwan), I. Chong (Kaohsiung, Taiwan), J. Yang (Hsinchu, Taiwan), P. Lu (Kaohsiung, Taiwan)
| |
Next generation sequencing reveals miR-431-3p and miR-1303 as immune-regulatory microRNA for active pulmonary tuberculosis through targeting MDR1/MMP16/RIPOR2 and ATG5 signaling
Y. Chen (Kaohsiung, Taiwan), C. Wu (Kaohsiung, Taiwan), M. Lin (Kaohsiung, Taiwan), C. Hsiao (Taoyuan, Taiwan), C. Lee (Kaohsiung, Taiwan)
| |
Role of complete-thoracentesis in TB-pleural-effusions, precluding residual-pleural-thickening, a case-control-study(300 cases)?
A. Qureshi (Lahore, Pakistan), M. Irfan (Lahore, Pakistan)
| |
Utility of the provocation coupled with the drug reintroduction test in the diagnosis of a hypersensitivity reaction to fixed-dose combination (FDC) of anti-TB drugs
A. Sana (Sousse, Tunisia), O. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), K. Amani (Kairouan, Tunisia), G. Imen (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
| |
Comparison of Indigenous tuberculin skin test (TST) antigen solution developed in India with Tubersol in diagnosing latent tuberculosis
D. Christopher (Vellore, India), N. Priya (Vellore, India), T. Balamugesh (Vellore, India), B. Isaac (Vellore, India), P. Samuel (Vellore, India)
| |
Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of activetuberculosis, latent infection and cured disease.
S. Díaz Fernández (Barcelona, Spain), R. Villar-Hernández (Barcelona, Spain), Z. Stojanovic (Barcelona, Spain), M. Fernández-Sanmartín (Barcelona, Spain), M. De Souza-Galvão (Barcelona, Spain), G. Tolosa (Temuco, Chile), A. Sánchez-Montalva (Barcelona, Spain), J. Abad (Barcelona, Spain), M. Jiménez-Fuentes (Barcelona, Spain), G. Safont (Barcelona, Spain), I. Romero (Barcelona, Spain), J. Sabrià (Barcelona, Spain), C. Prat (Barcelona, Spain), J. Domínguez (Barcelona, Spain), I. Latorre (Barcelona, Spain)
| |
Diagnostic accuracy of molecular assays for drug susceptibility testing of M.tuberculosis using a raw sputum and isolates strains.
V. Crudu (Chisinau, Republic of Moldova), S. Alexandru (Chisinau, Republic of Moldova), N. Ciobanu (Chisinau, Republic of Moldova), A. Codreanu (Chisinau, Republic of Moldova), E. Noroc (Chisinau, Republic of Moldova), D. Chesov (Chisinau, Republic of Moldova), T. Cohen (New Haven, United States)
| |
Comparison of QuantiFERON-TB Gold Plus vs tuberculin skin test in a healthy population in Mexico
A. Rendón (Monterrey, Mexico), A. Rosas Taraco (Monterrey, Mexico), J. Llaca Díaz (Monterrey, Mexico), B. Soto Monciváis (Monterrey, Mexico), A. Gonzalez Gutierrez (Monterrey, Mexico), M. Sánchez Otero (Monterrey, Mexico), A. Mercado Sánchez (Monterrey, Mexico)
| |
Utility of GeneXpert MTB/Rif for detection of drug resistance in tuberculous pleural effusion(TPE) in high endemic areas
R. Banka (Mumbai (Maharashtra), India), S. Naik (Mumbai (Maharashtra), India), J. Mullerpattan (Mumbai (Maharashtra), India), L. Pinto (Mumbai (Maharashtra), India), Z. Udwadia (Mumbai (Maharashtra), India), C. Rodrigues (Mumbai (Maharashtra), India)
| |
Comparing drug susceptibility testing for drug resistant TB using TB PCR and WGS
M. Park (London, United Kingdom), G. Satta (London, United Kingdom), O. Kon (London, United Kingdom)
| |
The role of autophagy associated gene expressions in the progression from latent TB infection to active pulmonary TB disease
Y. Fang (Kaohsiung City,, Taiwan), Y. Chen (Kaohsiung City,, Taiwan)
| |
A retrospective audit assessing the efficacy of the GeneXpert test in diagnosing TB in a paediatric population
R. White (LEICESTER, United Kingdom), S. Bandi (LEICESTER, United Kingdom)
| |
Multiparameter immunoprofiling differentiates progressive from nonprogressive nontuberculous mycobacteria lung disease (NTM-LD)
P. Marty (Rochester, United States), B. Pathakumari (Rochester, United States), V. Van Keulen (Rochester, United States), M. Shah (Rochester, United States), T. Peikert (Rochester, United States), P. Escalante (Rochester, United States)
| |
Identification of lung macrophage secreted biomarkers for the development of rapid, accurate and affordable point-of-care tuberculosis diagnosis test suitable in low income settings.
P. Essone (Lambarene, Gabon), B. Adegbite (Lambarene, Gabon), A. Alabi (Lambarene, Gabon), B. Lell (Lambarene, Gabon), A. Adegnika (Lambarene, Gabon), P. Kremsner (Tübingen, Germany), M. Grobusch (Amsterdam, Netherlands), S. Agnandji (Lambarene, Gabon)
| |